Volume 95, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Serological evidence of the epidemiological trends in infection is scarce, especially in nonendemic countries. We aimed to determine the antibody-positive rates over a 10-year period, and compare the trends between human immunodeficiency virus (HIV)–infected and –noninfected patients. We reviewed 3,514 patients who underwent antibody testing during the study periods, which were divided into five annual categories: 2004–2005, 2006–2007, 2008–2009, 2010–2011, and 2012–2013. Anti- antibody was assessed by indirect immunofluorescence assay. The antibody-positive rate increased yearly from 2004–2005 to 2012–2013 ( < 0.001), although there was no increase in the annual number of antibody tests. This trend was seen among males (18.6–28.3%; < 0.01), females (5.4–28.2%; < 0.01), HIV-infected patients (18.4–26.9%; < 0.001), and non-HIV-infected patients (14.6–36.8%; < 0.001), and HIV-infected men who have sex with men (19.4–29.1%; < 0.001). Among antibody-positive patients, there was a significant increase in the proportion of patients with high (≥ 1,600) titers (0.7–12.9%; < 0.001), whereas this trend was not seen in patients with low (100) or intermediate (200–800) titers ( = 0.282 and 0.409, respectively). This large hospital-based study demonstrated that positive anti- antibody rates increased over 10 years, even though the annual number of antibody tests remained constant. Moreover, this trend was identified in non-high-risk patients (females and non-HIV-infected patients) as well as in high-risk patients. The proportion of patients with high antibody titers significantly increased among the antibody-positive patients.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Article metrics loading...

Loading full text...

Full text loading...



  1. Stanley SL, Jr, 2003. Amoebiasis. Lancet 361: 10251034.[Crossref]
  2. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, Burney P, Carapetis J, Chen H, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, De Leo D, Degenhardt L, Delossantos A, Denenberg J, Des Jarlais DC, Dharmaratne SD, Dorsey ER, Driscoll T, Duber H, Ebel B, Erwin PJ, Espindola P, Ezzati M, Feigin V, Flaxman AD, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabriel SE, Gakidou E, Gaspari F, Gillum RF, Gonzalez-Medina D, Halasa YA, Haring D, Harrison JE, Havmoeller R, Hay RJ, Hoen B, Hotez PJ, Hoy D, Jacobsen KH, James SL, Jasrasaria R, Jayaraman S, Johns N, Karthikeyan G, Kassebaum N, Keren A, Khoo JP, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lipnick M, Lipshultz SE, Ohno SL, Mabweijano J, MacIntyre MF, Mallinger L, March L, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGrath J, Mensah GA, Merriman TR, Michaud C, Miller M, Miller TR, Mock C, Mocumbi AO, Mokdad AA, Moran A, Mulholland K, Nair MN, Naldi L, Narayan KM, Nasseri K, Norman P, O'Donnell M, Omer SB, Ortblad K, Osborne R, Ozgediz D, Pahari B, Pandian JD, Rivero AP, Padilla RP, Perez-Ruiz F, Perico N, Phillips D, Pierce K, Pope CA, 3rd Porrini E, Pourmalek F, Raju M, Ranganathan D, Rehm JT, Rein DB, Remuzzi G, Rivara FP, Roberts T, De Leon FR, Rosenfeld LC, Rushton L, Sacco RL, Salomon JA, Sampson U, Sanman E, Schwebel DC, Segui-Gomez M, Shepard DS, Singh D, Singleton J, Sliwa K, Smith E, Steer A, Taylor JA, Thomas B, Tleyjeh IM, Towbin JA, Truelsen T, Undurraga EA, Venketasubramanian N, Vijayakumar L, Vos T, Wagner GR, Wang M, Wang W, Watt K, Weinstock MA, Weintraub R, Wilkinson JD, Woolf AD, Wulf S, Yeh PH, Yip P, Zabetian A, Zheng ZJ, Lopez AD, Murray CJ, AlMazroa MA, Memish ZA, , 2012. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet 380: 20952128.[Crossref]
  3. Caballero-Salcedo A, Viveros-Rogel M, Salvatierra B, Tapia-Conyer R, Sepulveda-Amor J, Gutierrez G, Ortiz-Ortiz L, , 1994. Seroepidemiology of amebiasis in Mexico. Am J Trop Med Hyg 50: 412419.
  4. Chacin-Bonilla L, Mathews H, Dikdan Y, Guanipa N, , 1990. Seroepidemiologic study of amebiasis in a community of the State of Zulia, Venezuela. Rev Inst Med Trop Sao Paulo 32: 467473.[Crossref]
  5. Cross JH, Tsai SH, , 1982. Indirect hemagglutination antibody titers for Entamoeba histolytica in dried filter paper blood and sera. Southeast Asian J Trop Med Public Health 13: 6972.
  6. Pillai DR, Keystone JS, Sheppard DC, MacLean JD, MacPherson DW, Kain KC, , 1999. Entamoeba histolytica and Entamoeba dispar: epidemiology and comparison of diagnostic methods in a setting of nonendemicity. Clin Infect Dis 29: 13151318.[Crossref]
  7. Samie A, Barrett LJ, Bessong PO, Ramalivhana JN, Mavhandu LG, Njayou M, Guerrant RL, , 2010. Seroprevalence of Entamoeba histolytica in the context of HIV and AIDS: the case of Vhembe district, in South Africa's Limpopo province. Ann Trop Med Parasitol 104: 5563.[Crossref]
  8. Stauffer W, Abd-Alla M, Ravdin JI, , 2006. Prevalence and incidence of Entamoeba histolytica infection in South Africa and Egypt. Arch Med Res 37: 266269.[Crossref]
  9. Tsai JJ, Sun HY, Ke LY, Tsai KS, Chang SY, Hsieh SM, Hsiao CF, Yen JH, Hung CC, Chang SC, , 2006. Higher seroprevalence of Entamoeba histolytica infection is associated with human immunodeficiency virus type 1 infection in Taiwan. Am J Trop Med Hyg 74: 10161019.
  10. Uga S, Ono K, Kataoka N, Hasan H, , 1996. Seroepidemiology of five major zoonotic parasite infections in inhabitants of Sidoarjo, East Java, Indonesia. Southeast Asian J Trop Med Public Health 27: 556561.
  11. Yang B, Chen Y, Wu L, Xu L, Tachibana H, Cheng X, , 2012. Seroprevalence of Entamoeba histolytica infection in China. Am J Trop Med Hyg 87: 97103.[Crossref]
  12. del Carmen Sanchez-Guillen M, Velazquez-Rojas M, Salgado-Rosas H, Torres-Rasgado E, Perez-Fuentes R, Martinez-Munguia J, Talamas-Rohana P, , 2000. Seroprevalence of anti-Entamoeba histolytica antibodies by IHA and ELISA assays in blood donors from Puebla, Mexico. Arch Med Res 31: S53S54.[Crossref]
  13. Hung CC, Wu PY, Chang SY, Ji DD, Sun HY, Liu WC, Wu CH, Chang SC, , 2011. Amebiasis among persons who sought voluntary counseling and testing for human immunodeficiency virus infection: a case-control study. Am J Trop Med Hyg 84: 6569.[Crossref]
  14. Matsumoto T, , 2008. Trends of sexually transmitted diseases and antimicrobial resistance in Neisseria gonorrhoeae . Int J Antimicrob Agents 31 (Suppl 1): S35S39.[Crossref]
  15. Suguimoto SP, Techasrivichien T, Musumari PM, El-saaidi C, Lukhele BW, Ono-Kihara M, Kihara M, , 2014. Changing patterns of HIV epidemic in 30 years in east Asia. Curr HIV/AIDS Rep 11: 134145.[Crossref]
  16. James R, Barratt J, Marriott D, Harkness J, Stark D, , 2010. Seroprevalence of Entamoeba histolytica infection among men who have sex with men in Sydney, Australia. Am J Trop Med Hyg 83: 914916.[Crossref]
  17. Moran P, Ramos F, Ramiro M, Curiel O, Gonzalez E, Valadez A, Gomez A, Garcia G, Melendro EI, Ximenez C, , 2005. Infection by human immunodeficiency virus-1 is not a risk factor for amebiasis. Am J Trop Med Hyg 73: 296300.
  18. Fotedar R, Stark D, Beebe N, Marriott D, Ellis J, Harkness J, , 2007. Laboratory diagnostic techniques for Entamoeba species. Clin Microbiol Rev 20: 511532 table of contents.
  19. Tanyuksel M, Petri WA, Jr, 2003. Laboratory diagnosis of amebiasis. Clin Microbiol Rev 16: 713729.[Crossref]
  20. Nagata N, Shimbo T, Akiyama J, Niikura R, Watanabe K, Oka S, Uemura N, , 2012. Diagnostic accuracy of indirect immunofluorescence assay for intestinal invasive amebiasis and impact of HIV infection in a non-endemic country. Diagn Microbiol Infect Dis 74: 374378.[Crossref]
  21. Mithal S, Panigrahi HK, Mohapatra LN, Sunder S, , 1978. Indirect fluorescent antibody test in amoebiasis using axenic Entamoeba histolytica . Indian J Med Res 67: 367373.
  22. Ximenez C, Moran P, Rojas L, Valadez A, Gomez A, , 2009. Reassessment of the epidemiology of amebiasis: state of the art. Infect Genet Evol 9: 10231032.[Crossref]
  23. Ohnishi K, Kato Y, Imamura A, Fukayama M, Tsunoda T, Sakaue Y, Sakamoto M, Sagara H, , 2004. Present characteristics of symptomatic Entamoeba histolytica infection in the big cities of Japan. Epidemiol Infect 132: 5760.[Crossref]
  24. Ohnishi K, Murata M, , 1997. Present characteristics of symptomatic amebiasis due to Entamoeba histolytica in the east-southeast area of Tokyo. Epidemiol Infect 119: 363367.[Crossref]
  25. Nagata N, Shimbo T, Akiyama J, Nakashima R, Nishimura S, Yada T, Watanabe K, Oka S, Uemura N, , 2012. Risk factors for intestinal invasive amebiasis in Japan, 2003–2009. Emerg Infect Dis 18: 717724.[Crossref]
  26. Watanabe K, Aoki T, Nagata N, Tanuma J, Kikuchi Y, Oka S, Gatanaga H, , 2014. Clinical significance of high anti-Entamoeba histolytica antibody titer in asymptomatic HIV-1-infected individuals. J Infect Dis 209: 18011807.[Crossref]
  27. Suzuki J, Kobayashi S, Iku I, Murata R, Yanagawa Y, Takeuchi T, , 2008. Seroprevalence of Entamoeba histolytica infection in female outpatients at a sexually transmitted disease sentinel clinic in Tokyo, Japan. Jpn J Infect Dis 61: 175178.
  28. Tandon A, , 1981. Use of enzyme linked immunosorbent assay in intestinal and extra-intestinal amoebiasis (amoebic liver abscess). Trans R Soc Trop Med Hyg 75: 574575.[Crossref]
  29. Hira PR, Iqbal J, Al-Ali F, Philip R, Grover S, D'Almeida E, Al-Eneizi AA, , 2001. Invasive amebiasis: challenges in diagnosis in a non-endemic country (Kuwait). Am J Trop Med Hyg 65: 341345.

Data & Media loading...

  • Received : 21 Feb 2016
  • Accepted : 05 May 2016

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error